Cipher Pharmaceuticals Inc (CPH.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,785 | 1,807 | 1,806 | 1,797 | 1,807 |
| Income taxes - deferred | -369 | -1,214 | -8,710 | -1,243 | 512 |
| Accounts receivable | -2,390 | 1,454 | -1,081 | 1,743 | -95 |
| Accounts payable and accrued liabilities | 230 | 109 | 2,263 | -718 | -453 |
| Other Working Capital | -3,604 | -3,172 | 2,252 | 3,659 | -914 |
| Other Operating Activity | 7,398 | 5,538 | 12,198 | 5,520 | 5,163 |
| Operating Cash Flow | $3,050 | $4,522 | $8,728 | $10,758 | $6,020 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16 | 67 | -25 | 129 | 0 |
| Purchase Sale Intangibles | -239 | -559 | -93 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -80 | 0 |
| Investing Cash Flow | $-255 | $-492 | $-118 | $49 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -76 | -5,078 | -7,781 | -12,065 | -15,078 |
| Common Stock Repurchased | N/A | N/A | -1,658 | -1,580 | -2,143 |
| Other Financing Activity | 172 | 35 | -177 | 45 | 10 |
| Financing Cash Flow | $96 | $-5,043 | $-9,616 | $-13,600 | $-17,211 |
| Exchange Rate Effect | -190 | -70 | 75 | -122 | 530 |
| Beginning Cash Position | 6,410 | 7,493 | 8,424 | 11,339 | 22,000 |
| End Cash Position | 9,111 | 6,410 | 7,493 | 8,424 | 11,339 |
| Net Cash Flow | $2,891 | $-1,013 | $-1,006 | $-2,793 | $-11,191 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,050 | 4,522 | 8,728 | 10,758 | 6,020 |
| Capital Expenditure | -255 | -560 | -118 | -81 | N/A |
| Free Cash Flow | 2,795 | 3,962 | 8,610 | 10,677 | 6,020 |